Anders Waas
Chairman of the Board
Anders Waas, born 1957, is the Chairman of Sobrera Pharma since 2019. Waas has more than 35 years of experience with senior positions the pharmaceutical, biotechnology and med-tech industry. He has held senior global positions in business and product development. He has a background as head of business development in AstraZeneca, Actogenics and CV Therapeutics and most recently as CEO at TikoMed. As previously Vice President Business Development for CV Therapeutics, USA, he has many years of commercial and business development experience from the US market. Waas is currently Business Development Director at GUV, Gothenburg.
Ulf Johnsson
Board member
Ulf Jonsson, born 1949, is a board member in Sobrera Pharma since 2019. Jonsson, has 40 years of experience from the pharmaceutical industry, primarily within AstraZeneca. He has held senior, global positions covering areas such as pharmacokinetics, drug delivery, product development, portfolio management and business development. Ulf has extensive experience and knowledge of business development and negotiations in the pharma field and in the design and development of oral extended release formulations.
Elin Löf
Board member
Elin Löf, born in 1974, has more than 10 years of experience with product development from the pharmaceutical industry, across psychiatry and neurology portfolios. She currently holds a position as Director and Head of Medical Strategy and Communication Neurology at H Lundbeck A/S headquarters in Denmark. Löf further has experience with research in the area of Alcohol Use Disorder from the Sahlgrenska Academy, University of Gothenburg where she did her PhD and Postdoc.
Bo Söderpalm
Board member
Bo Söderpalm, born 1959, is a board member in Sobrera Pharma since 2019. Söderpalm, M.D., Ph.D., is Professor and Chief physician at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg. He is the Co-Founder of Sobrera Pharma. Söderpalm is an experienced senior researcher and clinician since 30 years and has performed several clinical studies in the area of alcohol abuse.
Frida Åkerblom
Board member
Frida Åkerblom has more than 20 years of experience in financial work, of which the last 10 years as CFO from Candyking, Aditro and Exeger. Frida started at Byggmästaren in autumn 2023.
Tomas Bergström
Board alternate
Tomas Bergström, born 1971, is a boardmember in Sobrera Pharma since 2023. He has more than 20 years’ experience of, investments, strategic business development and operational assignments in a leading position. Previously, he was Senior Vice President at OptiGroup and CEO of Textilia as well as a partner in Erneholm Haskel and Associate at Enskilda Securities, among other things. Bergström is currently the CEO of Byggmästare Anders J Ahlström Holding AB.
Andrea de Bejczy
Board alternate
Andrea de Bejczy, M.D., Ph.D., at the Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, University of Gothenburg is the Co-Founder of Sobrera Pharma. She is an experienced researcher and clinician and has performed several clinical studies in the area of alcohol abuse.
Klementina Österberg
Board alternate
CEO of GU Ventures and chair of GOKAP. Expert at building new companies. Experienced board member in the life science sector including Ectin Research AB, Aprit Biotech AB, Cereno Scientific AB, Texray AB, OnDosis AB, Iscaff Pharma AB, OligoNova Accelerate AB and Toleranzia AB.